NASDAQ:SWAV Shockwave Medical (SWAV) Stock Forecast, Price & News $198.35 +2.20 (+1.12%) (As of 02:50 PM ET) Add Compare Share Share Today's Range$195.17▼$199.3350-Day Range$194.33▼$275.9852-Week Range$172.50▼$320.54Volume233,492 shsAverage Volume556,155 shsMarket Capitalization$7.29 billionP/E Ratio30.90Dividend YieldN/APrice Target$292.29 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainabilityProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainability Shockwave Medical MarketRank™ ForecastAnalyst RatingModerate Buy2.86 Rating ScoreUpside/Downside48.9% Upside$292.29 Price TargetShort InterestHealthy4.52% of Shares Sold ShortDividend StrengthN/ASustainability-0.55Upright™ Environmental ScoreNews Sentiment1.02Based on 14 Articles This WeekInsider TradingSelling Shares$8.28 M Sold Last QuarterProj. Earnings Growth20.78%From $3.61 to $4.36 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.94 out of 5 starsMedical Sector46th out of 963 stocksSurgical & Medical Instruments Industry7th out of 97 stocks 3.4 Analyst's Opinion Consensus RatingShockwave Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.86, and is based on 6 buy ratings, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $292.29, Shockwave Medical has a forecasted upside of 48.9% from its current price of $196.25.Amount of Analyst CoverageShockwave Medical has only been the subject of 3 research reports in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted4.52% of the outstanding shares of Shockwave Medical have been sold short.Short Interest Ratio / Days to CoverShockwave Medical has a short interest ratio ("days to cover") of 3.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Shockwave Medical has recently increased by 30.71%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldShockwave Medical does not currently pay a dividend.Dividend GrowthShockwave Medical does not have a long track record of dividend growth. Previous Next 4.6 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreShockwave Medical has received a 72.86% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is driven by its "Diagnostic and treatment machines" and "Medical devices engineering" products. See details.Environmental SustainabilityThe Environmental Impact score for Shockwave Medical is -0.55. Previous Next 2.8 News and Social Media Coverage News SentimentShockwave Medical has a news sentiment score of 1.02. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.86 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 14 news articles for Shockwave Medical this week, compared to 6 articles on an average week.Search InterestOnly 14 people have searched for SWAV on MarketBeat in the last 30 days. This is a decrease of -39% compared to the previous 30 days.MarketBeat FollowsOnly 7 people have added Shockwave Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of -13% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Shockwave Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $8,276,394.00 in company stock.Percentage Held by InsidersOnly 3.40% of the stock of Shockwave Medical is held by insiders.Percentage Held by Institutions87.35% of the stock of Shockwave Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for Shockwave Medical are expected to grow by 20.78% in the coming year, from $3.61 to $4.36 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Shockwave Medical is 30.57, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 118.06.Price to Earnings Ratio vs. SectorThe P/E ratio of Shockwave Medical is 30.57, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 118.63.Price to Earnings Growth RatioShockwave Medical has a PEG Ratio of 42.40. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioShockwave Medical has a P/B Ratio of 13.87. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Shockwave Medical (NASDAQ:SWAV) StockShockWave Medical, Inc., a medical device company, develops intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters for use in our IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter for use in IVL System in large diameter vessels. It also provides product for the treatment of coronary artery disease, such as C2 IVL catheter and C2+IVL catheter that are two-emitter catheters for use in IVL system. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.Read More SWAV Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SWAV Stock News HeadlinesSeptember 22, 2023 | finance.yahoo.comMultiple Headwinds Pushed Shockwave Medical (SWAV) in Q2September 22, 2023 | finance.yahoo.comMultiple Tailwinds Pushed Shockwave Medical (SWAV) in Q2September 27, 2023 | Edge On The Street (Ad)Is Gold Really Boring?Many investors perceive gold as a "boring" investment. But according to MoneyWeek, that's a good thing. Gold helps investors sleep soundly as it preserves wealth and creates a hedge against inflation. Today, there's a unique way to invest in gold, with real advantages over coins and mining stocks. September 22, 2023 | finance.yahoo.comDirector Frank Watkins Sells 3,000 Shares of ShockWave Medical IncSeptember 21, 2023 | americanbankingnews.comDouglas Evan Godshall Sells 10,000 Shares of Shockwave Medical, Inc. (NASDAQ:SWAV) StockSeptember 19, 2023 | realmoney.thestreet.comDon't Be Shocked if Shockwave Medical Keeps Heading SouthSeptember 12, 2023 | finance.yahoo.comShockwave Medical Appoints Nick West as Associate Chief Medical OfficerSeptember 11, 2023 | 247wallst.comSWAV Stock Forecast: Riding the Sonic Wave of Innovation in Cardiovascular TreatmentSeptember 27, 2023 | Edge On The Street (Ad)Is Gold Really Boring?Many investors perceive gold as a "boring" investment. But according to MoneyWeek, that's a good thing. Gold helps investors sleep soundly as it preserves wealth and creates a hedge against inflation. Today, there's a unique way to invest in gold, with real advantages over coins and mining stocks. September 11, 2023 | finance.yahoo.comShockwave Medical, Inc.'s (NASDAQ:SWAV) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?September 6, 2023 | finance.yahoo.comHere’s Why Shockwave Medical (SWAV) Outperformed in Q2August 30, 2023 | benzinga.comPresident of ShockWave Medical Sold $819K In StockAugust 25, 2023 | markets.businessinsider.comBank of America Securities Remains a Buy on Shockwave Medical (SWAV)August 25, 2023 | markets.businessinsider.comPiper Sandler Sticks to Their Buy Rating for Shockwave Medical (SWAV)August 25, 2023 | finance.yahoo.comShockwave Medical, Inc. (NASDAQ:SWAV) Shares Could Be 27% Above Their Intrinsic Value EstimateAugust 24, 2023 | finance.yahoo.comShockwave Medical (SWAV) Exceeded Expectations in Q2August 17, 2023 | finance.yahoo.comMore Convertible Bond Issuers Are Saying No to Hedging Their BetsAugust 11, 2023 | msn.comShockwave Medical prices upsized private offering of $650MAugust 11, 2023 | finance.yahoo.comShockwave Medical Prices Upsized Private Offering of $650.0 Million of 1.00% Convertible Senior Notes Due 2028August 10, 2023 | msn.comMorgan Stanley Maintains ShockWave Medical (SWAV) Overweight RecommendationAugust 10, 2023 | finance.yahoo.comShockwave Medical Announces Proposed Private Offering of $500.0 Million of Convertible Senior NotesAugust 9, 2023 | msn.comShockwave Medical: Not Worth The PriceAugust 8, 2023 | benzinga.comShockWave Medical Second-Quarter Earnings: EPS Miss, Revenue Beat, Guidance RaisedAugust 8, 2023 | msn.comWells Fargo Maintains ShockWave Medical (SWAV) Equal-Weight RecommendationAugust 8, 2023 | finance.yahoo.comShockwave Medical (SWAV) Q2 Earnings Miss, Revenues Surge Y/YAugust 8, 2023 | finance.yahoo.comWhy Shockwave Medical Stock Dropped TodayAugust 8, 2023 | finance.yahoo.comQ2 2023 Shockwave Medical Inc Earnings CallSee More Headlines Receive SWAV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Shockwave Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address SWAV Company Calendar Last Earnings8/07/2023Today9/27/2023Next Earnings (Estimated)11/06/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:SWAV CUSIPN/A CIK1642545 Webwww.shockwavemedical.com Phone(877) 775-4846FaxN/AEmployees1,001Year FoundedN/APrice Target and Rating Average Stock Price Forecast$292.29 High Stock Price Forecast$330.00 Low Stock Price Forecast$251.00 Forecasted Upside/Downside+49.3%Consensus RatingModerate Buy Rating Score (0-4)2.86 Research Coverage7 Analysts Profitability EPS (Most Recent Fiscal Year)$6.42 Trailing P/E Ratio30.49 Forward P/E Ratio54.22 P/E Growth42.4Net Income$216 million Net Margins39.56% Pretax Margin24.90% Return on Equity47.48% Return on Assets36.24% Debt Debt-to-Equity Ratio0.04 Current Ratio5.69 Quick Ratio4.54 Sales & Book Value Annual Sales$489.73 million Price / Sales14.69 Cash Flow$6.17 per share Price / Cash Flow31.73 Book Value$14.15 per share Price / Book13.83Miscellaneous Outstanding Shares36,750,000Free Float35,501,000Market Cap$7.19 billion OptionableNot Optionable Beta0.98 Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesMr. Douglas E. Godshall M.B.A. (Age 58)Pres, CEO & Director Comp: $1.57MMr. Daniel Puckett MBA (Age 59)CFO, Principal Financial Officer & Sec. Comp: $797.38kMr. Isaac Zacharias (Age 48)Chief Commercial Officer Comp: $908.02kMr. Daniel Hawkins (Age 56)Founder and Sr. Advisor Mr. John M. Adams (Age 76)Co-Founder and Technical Advisor Mr. Mike MaszySr. VP of OperationsMs. Trinh Phung (Age 45)Chief Accounting Officer & Principal Accounting Officer Mr. Hajime Tada J.D.Gen. Counsel & Sec.Mr. Robert FletcherSr. VP of Marketing & Market AccessMr. Dave CoxVP of SalesMore ExecutivesKey CompetitorsStevanato GroupNYSE:STVNInspire Medical SystemsNYSE:INSPTeleflexNYSE:TFXPenumbraNYSE:PENGlobus MedicalNYSE:GMEDView All CompetitorsInsiders & InstitutionsBarclays PLCBought 5,301 shares on 9/21/2023Ownership: 0.142%Frank T WatkinsSold 3,000 sharesTotal: $627,690.00 ($209.23/share)Douglas Evan GodshallSold 10,000 sharesTotal: $2.13 M ($212.86/share)Isaac ZachariasSold 4,000 sharesTotal: $819,920.00 ($204.98/share)Douglas Evan GodshallSold 10,000 sharesTotal: $2.15 M ($214.62/share)View All Insider TransactionsView All Institutional Transactions SWAV Stock - Frequently Asked Questions Should I buy or sell Shockwave Medical stock right now? 7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Shockwave Medical in the last twelve months. There are currently 1 hold rating and 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" SWAV shares. View SWAV analyst ratings or view top-rated stocks. What is Shockwave Medical's stock price forecast for 2023? 7 brokers have issued 12 month target prices for Shockwave Medical's shares. Their SWAV share price forecasts range from $251.00 to $330.00. On average, they expect the company's stock price to reach $292.29 in the next year. This suggests a possible upside of 49.3% from the stock's current price. View analysts price targets for SWAV or view top-rated stocks among Wall Street analysts. How have SWAV shares performed in 2023? Shockwave Medical's stock was trading at $205.61 at the beginning of 2023. Since then, SWAV stock has decreased by 4.8% and is now trading at $195.72. View the best growth stocks for 2023 here. Are investors shorting Shockwave Medical? Shockwave Medical saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 1,660,000 shares, an increase of 30.7% from the August 31st total of 1,270,000 shares. Based on an average daily volume of 524,000 shares, the short-interest ratio is currently 3.2 days. View Shockwave Medical's Short Interest. When is Shockwave Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, November 6th 2023. View our SWAV earnings forecast. How were Shockwave Medical's earnings last quarter? Shockwave Medical, Inc. (NASDAQ:SWAV) posted its quarterly earnings data on Monday, August, 7th. The company reported $0.76 earnings per share for the quarter, missing the consensus estimate of $0.85 by $0.09. The company had revenue of $180.17 million for the quarter, compared to analysts' expectations of $173.79 million. Shockwave Medical had a trailing twelve-month return on equity of 47.48% and a net margin of 39.56%. The business's revenue for the quarter was up 49.2% compared to the same quarter last year. During the same period last year, the firm earned $0.68 earnings per share. What ETFs hold Shockwave Medical's stock? ETFs with the largest weight of Shockwave Medical (NASDAQ:SWAV) stock in their portfolio include Neuberger Berman Disrupters ETF (NBDS), Invesco Dorsey Wright Healthcare Momentum ETF (PTH), Janus Henderson Small/Mid Cap Growth Alpha ETF (JSMD), First Trust Indxx Medical Devices ETF (MDEV), Invesco S&P MidCap 400 Pure Growth ETF (RFG), Alger Mid Cap 40 ETF (FRTY), WisdomTree U.S. Growth & Momentum Fund (WGRO) and First Trust Health Care AlphaDEX Fund (FXH). What guidance has Shockwave Medical issued on next quarter's earnings? Shockwave Medical updated its FY 2023 earnings guidance on Monday, August, 7th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $725.00 million-$730.00 million, compared to the consensus revenue estimate of $716.10 million. What is Doug Godshall's approval rating as Shockwave Medical's CEO? 8 employees have rated Shockwave Medical Chief Executive Officer Doug Godshall on Glassdoor.com. Doug Godshall has an approval rating of 89% among the company's employees. What other stocks do shareholders of Shockwave Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Shockwave Medical investors own include NVIDIA (NVDA), Walt Disney (DIS), Block (SQ), Trade Desk (TTD), Salesforce (CRM), Roku (ROKU), PayPal (PYPL), DexCom (DXCM), Alibaba Group (BABA) and Okta (OKTA). When did Shockwave Medical IPO? (SWAV) raised $75 million in an initial public offering on Thursday, March 7th 2019. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. Morgan Stanley and BofA Merrill Lynch served as the underwriters for the IPO and Wells Fargo Securities and Canaccord Genuity were co-managers. What is Shockwave Medical's stock symbol? Shockwave Medical trades on the NASDAQ under the ticker symbol "SWAV." Who are Shockwave Medical's major shareholders? Shockwave Medical's stock is owned by a variety of institutional and retail investors. Top institutional investors include Bank Julius Baer & Co. Ltd Zurich (10.15%), BlackRock Inc. (9.90%), Artisan Partners Limited Partnership (3.13%), State Street Corp (2.77%), Geode Capital Management LLC (1.54%) and Allspring Global Investments Holdings LLC (1.30%). Insiders that own company stock include Antoine Papiernik, Colin Cahill, Dan Puckett, Douglas Evan Godshall, Frank T Watkins, Frank T Watkins, Isaac Zacharias, Kurt F Gallo, Laura Francis, Maria Sainz, Sara Toyloy and Trinh Phung. View institutional ownership trends. How do I buy shares of Shockwave Medical? Shares of SWAV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Shockwave Medical's stock price today? One share of SWAV stock can currently be purchased for approximately $195.72. How much money does Shockwave Medical make? Shockwave Medical (NASDAQ:SWAV) has a market capitalization of $7.19 billion and generates $489.73 million in revenue each year. The company earns $216 million in net income (profit) each year or $6.42 on an earnings per share basis. How many employees does Shockwave Medical have? The company employs 1,001 workers across the globe. How can I contact Shockwave Medical? Shockwave Medical's mailing address is 5403 Betsy Ross Drive, Santa Clara CA, 95054. The official website for the company is www.shockwavemedical.com. The company can be reached via phone at (877) 775-4846 or via email at investors@shockwavemedical.com. This page (NASDAQ:SWAV) was last updated on 9/27/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shockwave Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.